Cargando…

BRCA1 and STMN1 as prognostic markers in NSCLCs who received cisplatin-based adjuvant chemotherapy

OBJECTIVE: In this study, we aimed to investigate the predictive effect of BRCA1, STMN1, MAPT and TUBB3 on the prognosis of patients with non-small cell lung cancer (NSCLC). METHODS: Seventy NSCLC patients who received platinum-based chemotherapy from June 2009 to July 2011 were enrolled. The protei...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Mingxing, Li, Wanjun, Xing, Xuemei, Zhang, Dan, Lei, Jie, Li, Guoyin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5655245/ https://www.ncbi.nlm.nih.gov/pubmed/29113350 http://dx.doi.org/10.18632/oncotarget.20715

Ejemplares similares

Impact of Social Defeat Stress on DNA Methylation in Drd2, Nr3c1, and Stmn1 in Wild-type and Stmn1 Knock-out Mice
por: Oh, Young-Eun, et al.
Publicado: (2022)

Oncogenic miR-9 is a target of erlotinib in NSCLCs
por: Chen, Xi, et al.
Publicado: (2015)

Toxicity of (neo)adjuvant chemotherapy for BRCA1- and BRCA2-associated breast cancer
por: Drooger, Jan C., et al.
Publicado: (2016)

Neoadjuvant chemotherapy with Cisplatin in BRCA1 mutation carriers – results of treatment
por: Byrski, T, et al.
Publicado: (2012)

CENPA-driven STMN1 Transcription Inhibits Ferroptosis in Hepatocellular Carcinoma
por: Liang, Daomiao, et al.
Publicado: (2023)

PFKFB3 Inhibition Impairs Erlotinib-Induced Autophagy in NSCLCs
por: Lypova, Nadiia, et al.
Publicado: (2021)

Combined analysis of mRNA expression of ERCC1, BAG-1, BRCA1, RRM1 and TUBB3 to predict prognosis in patients with non-small cell lung cancer who received adjuvant chemotherapy
por: Leng, Xue-Feng, et al.
Publicado: (2012)

STMN1 as a novel prognostic biomarker in HCC correlating with immune infiltrates and methylation
por: Zhang, En-di, et al.
Publicado: (2022)

Clinical significance of UGT1A1 polymorphism and expression of ERCC1, BRCA1, TYMS, RRM1, TUBB3, STMN1 and TOP2A in gastric cancer
por: Cao, Yongkuan, et al.
Publicado: (2017)

Knockdown of STMN1 enhances osteosarcoma cell chemosensitivity through inhibition of autophagy
por: Wang, Zili, et al.
Publicado: (2017)

STMN1 accumulation is associated with dysplastic and neoplastic lesions in patients with ulcerative colitis
por: Osone, Katsuya, et al.
Publicado: (2019)

miR-223 increases gallbladder cancer cell sensitivity to docetaxel by downregulating STMN1
por: Lu, Wei, et al.
Publicado: (2016)

The Role of Native T1 and T2 Mapping Times in Identifying PD-L1 Expression and the Histological Subtype of NSCLCs
por: Bortolotto, Chandra, et al.
Publicado: (2023)

Personalized post-surgical care?—possible strategies for NSCLCs with EGFR mutation
por: Suda, Kenichi
Publicado: (2020)

STMN1 and MKI67 Are Upregulated in Uterine Leiomyosarcoma and Are Potential Biomarkers for its Diagnosis
por: Hu, Xianqing, et al.
Publicado: (2020)

Activation of an AKT/FOXM1/STMN1 pathway drives resistance to tyrosine kinase inhibitors in lung cancer
por: Li, Meng, et al.
Publicado: (2017)

Predictive Biomarkers for Checkpoint Inhibitor-Based Immunotherapy: The Galectin-3 Signature in NSCLCs
por: Capalbo, Carlo, et al.
Publicado: (2019)

High STMN1 level is associated with chemo-resistance and poor prognosis in gastric cancer patients
por: Bai, Tuya, et al.
Publicado: (2017)

High Tumoral STMN1 Expression Is Associated with Malignant Potential and Poor Prognosis in Patients with Neuroblastoma
por: Ogushi, Kenjiro, et al.
Publicado: (2023)

STMN1 Promotes Progesterone Production Via StAR Up-regulation in Mouse Granulosa Cells
por: Dou, Yun-De, et al.
Publicado: (2016)

A Single Institution Experience of Incorporation of Cisplatin into Adjuvant Chemotherapy for Patients With Triple-Negative Breast Cancer of Unknown BRCA Mutation Status
por: Su, Ying-Wen, et al.
Publicado: (2018)

Activity of Birinapant, a SMAC Mimetic Compound, Alone or in Combination in NSCLCs With Different Mutations
por: Colombo, Marika, et al.
Publicado: (2020)

PIK3CA Mutation as Potential Poor Prognostic Marker in Asian Female Breast Cancer Patients Who Received Adjuvant Chemotherapy
por: Cho, Yoon Ah, et al.
Publicado: (2022)

STMN-1 is a potential marker of lymph node metastasis in distal esophageal adenocarcinomas and silencing its expression can reverse malignant phenotype of tumor cells
por: Akhtar, Javed, et al.
Publicado: (2014)

Questioning the Association of the STMN2 Dinucleotide Repeat With Amyotrophic Lateral Sclerosis
por: Ross, Jay P., et al.
Publicado: (2022)

Cisplatin in breast cancer treatment in BRCA1 carriers
por: Gronwald, Jacek, et al.
Publicado: (2012)

PTEN loss promotes oncogenic function of STMN1 via PI3K/AKT pathway in lung cancer
por: Xun, Guangsu, et al.
Publicado: (2021)

Survival after recurrence in patients with gastric cancer who receive S-1 adjuvant chemotherapy: exploratory analysis of the ACTS-GC trial
por: Ito, Seiji, et al.
Publicado: (2018)

Landscape and Predictive Significance of the Structural Classification of EGFR Mutations in Chinese NSCLCs: A Real-World Study
por: Gu, Linping, et al.
Publicado: (2022)

Adjuvant chemotherapy after radical cystectomy: Do all patients who need chemotherapy after surgery actually receive it?
por: Croock, Roy, et al.
Publicado: (2023)

Metastatic NSCLCs With Limited Tissues: How to Effectively Identify Driver Alterations to Guide Targeted Therapy in Chinese Patients
por: Li, Weihua, et al.
Publicado: (2021)

Combination chemotherapy with S-1 plus cisplatin for gastric cancer that recurs after adjuvant chemotherapy with S-1: multi-institutional retrospective analysis
por: Shitara, Kohei, et al.
Publicado: (2011)

Aberrantly high activation of a FoxM1–STMN1 axis contributes to progression and tumorigenesis in FoxM1-driven cancers
por: Liu, Jun, et al.
Publicado: (2021)

Analysis of neuroendocrine clones in NSCLCs using an immuno-guided laser-capture microdissection-based approach
por: Baldelli, Elisa, et al.
Publicado: (2022)

Rs11479 in Thymidine Phosphorylase Associated with Prognosis of Patients with Colorectal Cancer Who Received Capecitabine-Based Adjuvant Chemotherapy
por: Jia, Xiongjie, et al.
Publicado: (2023)

LncRNA LINC01116 Promotes the Development of Colorectal Cancer by Targeting miR-9-5p/STMN1
por: Bi, Chongyao, et al.
Publicado: (2020)

Circβ-catenin promotes tumor growth and Warburg effect of gallbladder cancer by regulating STMN1 expression
por: Wang, Shouhua, et al.
Publicado: (2021)

BRCA1 mRNA Expression as a Predictive and Prognostic Marker in Advanced Esophageal Squamous Cell Carcinoma Treated with Cisplatin- or Docetaxel-Based Chemotherapy/Chemoradiotherapy
por: Gao, Yong, et al.
Publicado: (2013)

Prognosis of selected triple negative apocrine breast cancer patients who did not receive adjuvant chemotherapy
por: Montagna, Emilia, et al.
Publicado: (2020)

Retraction Note: STMN-1 is a potential marker of lymph node metastasis in distal esophageal adenocarcinomas and silencing its expression can reverse malignant phenotype of tumor cells
por: Akhtar, Javed, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_skfudm5rvfluv0ovme59o4gjgu